Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Wegovy, Ozempic, and other weight loss drugs have drastically changed the treatment of obesity, but consumers have complained about high out-of-pocket prices. Medicare does not cover the two ...
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback